Lexeo Therapeutics (NasdaqGM:LXEO) Update / Briefing October 07, 2025 08:00 AM ET Company ParticipantsLouis Tamayo - CFONolan Townsend Richard - CEOLili Nsongo - Biotechnology Equity Research VPSandi See Tai - Chief Development OfficerJosé Manuel Otero - Chief Technical OfficerEric Adler - Chief Medical Officer and Head of ResearchConference Call ParticipantsTessa Romero - Senior Biotechnology Equity Research AnalystLeland Gershell - Managing Director and Senior Biotechnology AnalystNone - AnalystNone - Ana ...